局部晚期宫颈癌根治性放化疗后毒性的预测因素:一项系统综述
该研究系统检索并分析了局部晚期宫颈癌(LACC)接受以铂类为基础的根治性放化疗后胃肠道、泌尿生殖系统和阴道毒性及功能不全骨折的预测因素。共纳入26项低或中等偏倚风险研究,发现近距离放疗相关胃肠道剂量体积参数(如直肠和肠道EQD2 D2 cm3)及(直肠)阴道点剂量与毒性相关。作者建议更大规模研究评估功能不全骨折、外照射剂量水平并量化预测因素与毒性的关系以促进NTCP模型开发。
要点
- 近距离放疗相关胃肠道剂量体积参数(直肠和肠道EQD2 D2 cm3)常与毒性相关,而泌尿生殖系统剂量体积参数不常相关。
- (直肠)阴道点剂量可预测毒性,总参考空气比释动能和阴道参考长度也与毒性相关。
- 仅1项研究评估功能不全骨折,显示治疗前骨密度较低与功能不全骨折相关。
核心结论
- 本综述发现多个候选毒性预测因素,包括近距离放疗相关胃肠道剂量体积参数、(直肠)阴道点剂量、总参考空气比释动能和阴道参考长度等。
- 作者建议更大规模研究应考虑功能不全骨折、评估外照射剂量水平并量化预测因素与治疗相关毒性的关系,以进一步促进NTCP模型的临床开发。
研究设计与样本
- 系统综述,系统检索评估局部晚期宫颈癌女性接受以铂类为基础的根治性放化疗后预测因素与毒性关系的研究。
- 采用预后研究质量(QUIPS)工具评估偏倚风险,排除高风险研究,最终纳入26项低或中等偏倚风险研究(共检索到73项研究)。
主要发现
- 近距离放疗相关胃肠道剂量体积参数,包括直肠和肠道2 Gy分次等效剂量(EQD2)D2 cm3,常与毒性相关,而泌尿生殖系统剂量体积参数不常相关。
- (直肠)阴道点剂量可预测毒性;总参考空气比释动能和阴道参考长度与毒性相关。
- 少数研究评估外照射剂量体积参数,发现直肠EQD2 V30 Gy、V40 Gy和V55 Gy,以及肠道和膀胱EQD2 V40 Gy为毒性预测因素。
- 患者特征与胃肠道毒性的关系不一致;诊断时阴道受累范围、基线症状和肥胖预测泌尿生殖系统或阴道毒性。
- 仅1项研究评估功能不全骨折,显示治疗前骨密度较低与功能不全骨折相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 患者特征与胃肠道毒性的关系不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Women with locally advanced cervical cancer (LACC) undergoing primary platinum-based chemoradiotherapy and brachytherapy often experience toxicities. Normal-tissue complication probability (NTCP) models quantify toxicity risk and aid in optimizing radiation therapy to minimize side effects. However, it is unclear which predictors to include in an NTCP model. The aim of this systematic review was to provide an overview of the identified predictors contributing to gastrointestinal (GI), genitourinary (GU), and vaginal toxicities and insufficiency fractures for LACC. METHODS AND MATERIALS: A systematic search was performed and articles evaluating the relationship between predictors and toxicities in women with LACC treated with primary chemoradiation were included. The Quality In Prognosis Studies tool was used to assess risk of bias, with high-risk studies being excluded from further analysis. Relationships between dose-volume parameters, patient and treatment characteristics, and toxicity endpoints were analyzed. RESULTS: Seventy-three studies were identified. Twenty-six had a low or moderate risk of bias and were therefore included. Brachytherapy-related dose-volume parameters of the GI tract, including rectum and bowel equivalent dose in 2 Gy fractions (EQD2) D2 cm3, were frequently related to toxicities, unlike GU dose-volume parameters. Furthermore, (recto)vaginal point doses predicted toxicities. Few studies evaluated external beam radiation therapy dose-volume parameters and identified rectum EQD2 V30 Gy, V40 Gy, and V55 Gy, bowel and bladder EQD2 V40 Gy as toxicity predictors. Also, total reference air kerma and vaginal reference length were associated with toxicities. Relationships between patient characteristics and GI toxicity were inconsistent. The extent of vaginal involvement at diagnosis, baseline symptoms, and obesity predicted GU or vaginal toxicities. Only 1 study evaluated insufficiency fractures and demonstrated lower pretreatment bone densities to be associated. CONCLUSIONS: This review detected multiple candidate predictors of toxicity. Larger studies should consider insufficiency fractures, assess dose levels from external beam radiation therapy, and quantify the relationship between the predictors and treatment-related toxicities in women with LACC to further facilitate NTCP model development for clinical use.
引用
- Corbeau A, Heemsbergen WD, Kuipers SC, et al. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys. 2023. PMID: 37979708. doi:10.1016/j.ijrobp.2023.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。